Patents by Inventor Jason Scott Stumhofer

Jason Scott Stumhofer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • WSX-1/P28 as a target for anti-inflammatory responses
    Patent number: 9683026
    Abstract: Compositions and methods relating to WSX-1 and p28 (IL-30) are provided. In particular, methods of treating inflammatory conditions in mammalian subjects using various WSX-1, p28, EBI3, and gp130 polypeptides and complexes or moieties that bind to or modulate activity of such complexes are described. Isolated or recombinant complexes including soluble WSX-1 or gp130 polypeptides, isolated or recombinant WSX-1 fusion proteins, and isolated or recombinant p28 fusion proteins are also described.
    Type: Grant
    Filed: July 18, 2007
    Date of Patent: June 20, 2017
    Assignee: THE TRUSTEES OF THE UNIVERSITY OF PENNSLYVANIA
    Inventors: Christopher A. Hunter, Jason Scott Stumhofer
  • Use of IL-27-P28 to antagonize IL-6 mediated signaling
    Publication number: 20120039840
    Abstract: Provided are methods increasing, or, alternatively, decreasing IL-6 and/or gp130-mediated signaling in mammalian subjects using p28. Methods of preventing and/or treating autoimmune disorders, cancer, transplant rejection, and other IL-6-associated diseases, as well as methods of enhancing an IL-6-mediated immune response, are also described.
    Type: Application
    Filed: December 2, 2009
    Publication date: February 16, 2012
    Inventors: Christopher A. Hunter, Jason Scott Stumhofer